| Stage | MRVL | % of rev | CEG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.7B | 100.00% | $9.6B | 100.00% | CEG ×3.49 |
| Gross profit | $1.5B | 53.14% | $5.2B | 53.93% | CEG +0.8pp |
| Operating income | $460M | 16.78% | $2.5B | 26.09% | CEG +9.3pp |
| Pre-tax income | $378M | 13.81% | $2.2B | 23.36% | CEG +9.6pp |
| Net income | $308M | 11.24% | $1.8B | 19.21% | CEG +8.0pp |
| Stage | MRVL | CEG | Gap · A − B |
|---|---|---|---|
| Revenue | $2.7B100.00% | $9.6B100.00% | CEG ×3.49 |
| Gross profit | 53.14%$1.5B | 53.93%$5.2B | CEG +0.8pp |
| Operating income | 16.78%$460M | 26.09%$2.5B | CEG +9.3pp |
| Pre-tax income | 13.81%$378M | 23.36%$2.2B | CEG +9.6pp |
| Net income |
| 11.24%$308M |
| 19.21%$1.8B |
| CEG +8.0pp |